Suppression of heat- and polyglutamine-induced cytotoxicity by nonsteroidal anti-inflammatory drugs

被引:17
|
作者
Ishihara, K [1 ]
Yamagishi, N [1 ]
Hatayama, T [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Biochem, Yamashima Ku, Kyoto 6078414, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 22期
关键词
heat shock proteins; indomethacin; nonsteroidal anti-inflammatory drugs; nordihydroguaiaretic acid; polyglutamine disease;
D O I
10.1111/j.1432-1033.2004.04419.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have shown that sodium salicylate activates the heat shock promoter and induces the expression of heat shock proteins (hsps), with a concomitant increase in the thermotolerance of cells. To determine whether these effects are generally displayed by nonsteroidal anti-inflammatory drugs (NSAIDs), we examined the effects of a cyclooxygenase inhibitor, indomethacin, and a lipoxygenase inhibitor, nordihydroguaiaretic acid. Both inhibitors up-regulated the hsp promoter at 37degreesC through the activation of heat shock factors, and increased cellular levels of hsps in mammalian cells, although the degree of the expression of hsps and thermotolerance of cells differed depending on the drugs. Furthermore, NSAIDs such as sodium salicylate and indomethacin suppressed the protein aggregation and apoptosis caused by an expanded polyglutamine tract in a cellular model of polyglutamine disease. These findings suggest that NSAIDs generally induce the expression of hsps in mammalian cells and may be used for the protection of cells against deleterious stressors and neurodegenerative diseases.
引用
收藏
页码:4552 / 4558
页数:7
相关论文
共 50 条
  • [31] Therapy with nonsteroidal, anti-inflammatory drugs
    Bauer, H
    Märker-Hermann, E
    ORTHOPADE, 2003, 32 (12): : 1088 - 1094
  • [32] Nonsteroidal Anti-Inflammatory Drugs and the Kidney
    Hoerl, Walter H.
    PHARMACEUTICALS, 2010, 3 (07): : 2291 - 2321
  • [33] Nonsteroidal anti-inflammatory drugs in the cat
    Jones, Ronald S.
    VETERINARY ANAESTHESIA AND ANALGESIA, 2007, 34 (04) : 225 - 227
  • [34] Pharmacogenetics of nonsteroidal anti-inflammatory drugs
    J E Wyatt
    W L Pettit
    S Harirforoosh
    The Pharmacogenomics Journal, 2012, 12 : 462 - 467
  • [35] Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
    Marjoribanks, Jane
    Proctor, Michelle
    Farquhar, Cindy
    Derks, Roos S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [36] The epidemiology of nonsteroidal anti-inflammatory drugs
    Tenenbaum, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1999, 13 (02): : 119 - 122
  • [37] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND HYPERTENSION
    KISCH, ES
    FISCHEL, B
    YARON, M
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (04) : 344 - 345
  • [38] Nonsteroidal Anti-Inflammatory Drugs in Orthopaedics
    Abdul-Hadi, Omar
    Parvizi, Javad
    Austin, Matthew S.
    Viscusi, Eugene
    Einhorn, Thomas
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (08): : 2020 - 2027
  • [39] Pharmacogenetics of nonsteroidal anti-inflammatory drugs
    Wyatt, J. E.
    Pettit, W. L.
    Harirforoosh, S.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (06): : 462 - 467
  • [40] Nonsteroidal Anti-Inflammatory Drugs and the Heart
    Patrono, Carlo
    Baigent, Colin
    CIRCULATION, 2014, 129 (08) : 907 - 916